INOVIA® Vein Specialty Center participated in the Recent Veclose Trial, the results of which were recently published in the Journal of Vascular Surgery with Dr. Jones as a co-author. Based in part on the results from this pivotal clinical trial, the U.S. Food and Drug Administration approval for VenaSeal(TM) closure system. The VenaSeal procedure is the only non-tumescent, non-thermal, non-sclerosant procedure approved for use in the U.S. that uses a specially formulated medical adhesive that closes the vein. The device is manufactured by Medtronic and should be commercially available later this year.
